Inalways (5398) - Total Assets
Based on the latest financial reports, Inalways (5398) holds total assets worth NT$600.79 Million TWD (≈ $18.93 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 5398 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Inalways - Total Assets Trend (2015–2025)
This chart illustrates how Inalways's total assets have evolved over time, based on quarterly financial data. See 5398 net asset value for net asset value and shareholders' equity analysis.
Inalways - Asset Composition Analysis
Current Asset Composition (December 2025)
Inalways's total assets of NT$600.79 Million consist of 47.3% current assets and 52.7% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 9.9% |
| Accounts Receivable | NT$60.97 Million | 10.2% |
| Inventory | NT$48.18 Million | 8.0% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Inalways's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 5398 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inalways's current assets represent 47.3% of total assets in 2025, a decrease from 79.8% in 2015.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, down from 31.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 10.2% of total assets.
Inalways Competitors by Total Assets
Key competitors of Inalways based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Livzon Pharmaceutical Group Inc
SHE:000513
|
China | CN¥24.19 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥3.63 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.56 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Canopy Growth Corp
TO:WEED
|
Canada | CA$1.11 Billion |
|
LAVIPHARM S.A. NA EO 1
F:BXA0
|
Germany | €125.48 Million |
Inalways - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.36 | 3.04 | 5.33 |
| Quick Ratio | 3.62 | 2.54 | 3.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$219.11 Million | NT$195.06 Million | NT$360.20 Million |
Inalways - Advanced Valuation Insights
This section examines the relationship between Inalways's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.86 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -8.0% |
| Total Assets | NT$600.79 Million |
| Market Capitalization | $22.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Inalways's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Inalways's assets decreased by 8.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Inalways (2015–2025)
The table below shows the annual total assets of Inalways from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$600.79 Million ≈ $18.93 Million |
-8.02% |
| 2024-12-31 | NT$653.17 Million ≈ $20.58 Million |
+17.34% |
| 2023-12-31 | NT$556.64 Million ≈ $17.54 Million |
-8.56% |
| 2022-12-31 | NT$608.73 Million ≈ $19.18 Million |
-6.04% |
| 2021-12-31 | NT$647.84 Million ≈ $20.41 Million |
+0.08% |
| 2020-12-31 | NT$647.31 Million ≈ $20.39 Million |
-3.18% |
| 2019-12-31 | NT$668.56 Million ≈ $21.06 Million |
+6.17% |
| 2018-12-31 | NT$629.72 Million ≈ $19.84 Million |
-19.02% |
| 2017-12-31 | NT$777.58 Million ≈ $24.50 Million |
+1.10% |
| 2016-12-31 | NT$769.13 Million ≈ $24.23 Million |
+124.18% |
| 2015-12-31 | NT$343.08 Million ≈ $10.81 Million |
-- |
About Inalways
Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.